Pharmacokinetic-Pharmacodynamic and Dose-Response Relationships of Antituberculosis Drugs: Recommendations and Standards for Industry and Academia
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetic-Pharmacodynamic and Dose-Response Relationships of Antituberculosis Drugs: Recommendations and Standards for Industry and Academia
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 211, Issue suppl 3, Pages S96-S106
Publisher
Oxford University Press (OUP)
Online
2015-05-26
DOI
10.1093/infdis/jiu610
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of Nonlinear Interactions of Pharmacokinetics and MICs on Sputum Bacillary Kill Rates as a Marker of Sterilizing Effect in Tuberculosis
- (2014) Emmanuel Chigutsa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Redefining Multidrug-Resistant Tuberculosis Based on Clinical Response to Combination Therapy
- (2014) Tawanda Gumbo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Correlation of plasma anti-tuberculosis drug levels with subsequent development of hepatotoxicity
- (2014) A. Satyaraddi et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- The pyrazinamide susceptibility breakpoint above which combination therapy fails
- (2014) T. Gumbo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Correlation between Genotypic and Phenotypic Testing for Resistance to Rifampin in Mycobacterium tuberculosis Clinical Isolates in Haiti: Investigation of Cases with Discrepant Susceptibility Results
- (2014) Oksana Ocheretina et al. PLoS One
- Re-Evaluation of the Critical Concentration for Ethambutol Antimicrobial Sensitivity Testing on the MGIT 960
- (2014) Sara Christianson et al. PLoS One
- Randomized Dose-Ranging Study of the 14-Day Early Bactericidal Activity of Bedaquiline (TMC207) in Patients with Sputum Microscopy Smear-Positive Pulmonary Tuberculosis
- (2013) Andreas H. Diacon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Moxifloxacin Population Pharmacokinetics and Model-Based Comparison of Efficacy between Moxifloxacin and Ofloxacin in African Patients
- (2013) Simbarashe P. Zvada et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Approval of a Tuberculosis Drug Based on a Paradoxical Surrogate Measure
- (2013) Jerry Avorn JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Phenotypically occult multidrug-resistant Mycobacterium tuberculosis: dilemmas in diagnosis and treatment
- (2013) J. Ho et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes
- (2013) J. G. Pasipanodya et al. JOURNAL OF INFECTIOUS DISEASES
- Feasibility of a Fixed-Dose Regimen of Pyrazinamide and Its Impact on Systemic Drug Exposure and Liver Safety in Patients with Tuberculosis
- (2012) Tarjinder Sahota et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Meta-Analysis of Clinical Studies Supports the Pharmacokinetic Variability Hypothesis for Acquired Drug Resistance and Failure of Antituberculosis Therapy
- (2012) Jotam G. Pasipanodya et al. CLINICAL INFECTIOUS DISEASES
- Protein Binding: Do We Ever Learn?
- (2011) Markus A. Zeitlinger et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dose-Dependent Activity of Pyrazinamide in Animal Models of Intracellular and Extracellular Tuberculosis Infections
- (2011) Zahoor Ahmad et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Saturability of Granulocyte Kill of Pseudomonas aeruginosa in a Murine Model of Pneumonia
- (2011) G. L. Drusano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Pharmacodynamics of TMC207 and ItsN-Desmethyl Metabolite in a Murine Model of Tuberculosis
- (2011) Marie-Claude Rouan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?
- (2011) J. van Ingen et al. CLINICAL INFECTIOUS DISEASES
- Low-level rifampicin-resistant Mycobacterium tuberculosis strains raise a new therapeutic challenge [Short communication]
- (2011) J. van Ingen et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Clinical failures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis
- (2011) D. A. Williamson et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- In SilicoChildren and the Glass Mouse Model: Clinical Trial Simulations To Identify and Individualize Optimal Isoniazid Doses in Children with Tuberculosis
- (2010) Prakash M. Jeena et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- An Oracle: Antituberculosis Pharmacokinetics-Pharmacodynamics, Clinical Correlation, and Clinical Trial Simulations To Predict the Future
- (2010) Jotam Pasipanodya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Burden on Granulocyte Clearance of Bacteria in a Mouse Thigh Infection Model
- (2010) G. L. Drusano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical and Toxicodynamic Evidence that High-Dose Pyrazinamide Is Not More Hepatotoxic than the Low Doses Currently Used
- (2010) J. G. Pasipanodya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New Susceptibility Breakpoints for First-Line Antituberculosis Drugs Based on Antimicrobial Pharmacokinetic/Pharmacodynamic Science and Population Pharmacokinetic Variability
- (2010) T. Gumbo ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Early Bactericidal Activity and Pharmacokinetics of PA-824 in Smear-Positive Tuberculosis Patients
- (2010) A. H. Diacon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- PA-824 Exhibits Time-Dependent Activity in a Murine Model of Tuberculosis
- (2010) Zahoor Ahmad et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efflux‐Pump–Derived Multiple Drug Resistance to Ethambutol Monotherapy inMycobacterium tuberculosisand the Pharmacokinetics and Pharmacodynamics of Ethambutol
- (2010) Shashikant Srivastava et al. JOURNAL OF INFECTIOUS DISEASES
- The Combination of Rifampin plus Moxifloxacin Is Synergistic for Suppression of Resistance but Antagonistic for Cell Kill of Mycobacterium tuberculosis as Determined in a Hollow-Fiber Infection Model
- (2010) G. L. Drusano et al. mBio
- Population Modeling and Monte Carlo Simulation Study of the Pharmacokinetics and Antituberculosis Pharmacodynamics of Rifampin in Lungs
- (2009) S. Goutelle et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Paradoxical Effect of Isoniazid on the Activity of Rifampin-Pyrazinamide Combination in a Mouse Model of Tuberculosis
- (2009) D. Almeida et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics-Pharmacodynamics of Pyrazinamide in a Novel In Vitro Model of Tuberculosis for Sterilizing Effect: a Paradigm for Faster Assessment of New Antituberculosis Drugs
- (2009) T. Gumbo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Isoniazid, Rifampin, Ethambutol, and Pyrazinamide Pharmacokinetics and Treatment Outcomes among a Predominantly HIV‐Infected Cohort of Adults with Tuberculosis from Botswana
- (2009) Sekai Chideya et al. CLINICAL INFECTIOUS DISEASES
- The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
- (2009) Andreas H. Diacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Protein Binding on the Pharmacological Activity of Highly Bound Antibiotics
- (2008) S. Schmidt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Early Bactericidal Activity and Pharmacokinetics of the Diarylquinoline TMC207 in Treatment of Pulmonary Tuberculosis
- (2008) R. Rustomjee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started